Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Mazandaran University of Medical Sciences

Iran

Country: Iran

Ownership: Private

Established: 1988-01-01

Employees: -

Market Cap: -

Website: http://wwww.mazums.ac.ir

Clinical Trials

Post-stroke Seizure and Epilepsy Following Thrombolytic Therapy

Completed

Conditions: Post-stroke Seizure
Post-stroke Epilepsy
Thrombolytic (t-PA) Treatment

First Posted Date: 2025-02-06

Last Posted Date: 2025-02-06

Lead Sponsor: Mazandaran University of Medical Sciences

Target Recruit Count: 199

Registration Number: NCT06812000

Locations: 🇮🇷
Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran, Islamic Republic of

Topical 5-Fluorouracil (5FU) Plus Calcipotriol in Children with Palmoplantar Wart

Not Applicable

Not yet recruiting

Conditions: Common Warts

Interventions: Drug: Topical 5% fluorouracil cream
Drug: Topical 0.005% calcipotriol ointment
Drug: Placebo

First Posted Date: 2024-12-17

Last Posted Date: 2024-12-17

Lead Sponsor: Mazandaran University of Medical Sciences

Target Recruit Count: 60

Registration Number: NCT06737406

Locations: 🇮🇷
Iran, Sari, Mazandaran, Iran, Islamic Republic of

Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke

Phase 2

Recruiting

Conditions: Ischemic Stroke
Transient Ischemic Attack

Interventions: Drug: Ticagrelor 60 + Aspirin
Drug: Ticagrelor 90 + aspirin

First Posted Date: 2024-10-22

Last Posted Date: 2025-04-27

Lead Sponsor: Mazandaran University of Medical Sciences

Target Recruit Count: 100

Registration Number: NCT06653348

Locations: 🇮🇷
Mazandaran province, Sari,Iran, Sari, Mazandaran, Iran, Islamic Republic of

Comparison Study of Electrocardiogram Indexes in Patients With Epilepsy, Patients With First Seizure and Normal Population

Completed

Conditions: Patients With Epilepsy
Patients With First Seizure
Normal Population

Interventions: Diagnostic Test: Electrocardiography

First Posted Date: 2024-09-23

Last Posted Date: 2024-09-23

Lead Sponsor: Mazandaran University of Medical Sciences

Target Recruit Count: 70

Registration Number: NCT06608784

Locations: 🇮🇷
Mazandaran University of Medical Sciences, Sari, Mazandaran, Iran, Islamic Republic of

Levetiracetam Versus Valproate in Idiopathic Generalized Epilepsy

Completed

Conditions: Treatment of Idiopathic Generalized Epilepsy

Interventions: Drug: Levetiracetam
Drug: Sodium valproate

First Posted Date: 2024-05-01

Last Posted Date: 2024-05-02

Lead Sponsor: Mazandaran University of Medical Sciences

Target Recruit Count: 169

Registration Number: NCT06393309

Locations: 🇮🇷
Bu Ali Sina Hospital, Sari, Mazandaran, Iran, Islamic Republic of

Baricitinib Versus Azathioprine in Patients With Moderate-to-Severe Atopic Dermatitis

Not Applicable

Active, not recruiting

Conditions: Atopic Dermatitis

Interventions: Drug: Azathioprine 1.5-2.5 mg/kg
Drug: Baricitinib 4 MG

First Posted Date: 2023-08-01

Last Posted Date: 2025-05-06

Lead Sponsor: Mazandaran University of Medical Sciences

Target Recruit Count: 40

Registration Number: NCT05969730

Locations: 🇮🇷
Iran, Sari, Mazandaran, Iran, Islamic Republic of

Probiotic in Treatment of Adult Patients With Drug-resistant Epilepsy

Phase 4

Completed

Conditions: Epilepsy
Treatment

Interventions: Drug: Probiotic

First Posted Date: 2021-12-16

Last Posted Date: 2022-01-11

Lead Sponsor: Mazandaran University of Medical Sciences

Target Recruit Count: 42

Registration Number: NCT05160350

Locations: 🇮🇷
Bu Ali Sina Hospital, Sari, Mazandaran, Iran, Islamic Republic of

Corticosteroid Effects on Asymptomatic Gadolinium-enhancing Lesions in Multiple Sclerosis

Phase 2

Conditions: Magnetic Resonance Imaging
Multiple Sclerosis, Relapsing-Remitting
Methylprednisolone

Interventions: Drug: Methylprednisolone succinate
Drug: Normal saline

First Posted Date: 2021-07-28

Last Posted Date: 2021-08-05

Lead Sponsor: Mazandaran University of Medical Sciences

Target Recruit Count: 104

Registration Number: NCT04979650

Locations: 🇮🇷
Mazandaran University of medical sciences, Sari, Mazandaran, Iran, Islamic Republic of

Ciprofloxacin in Drug-resistant Epilepsy

Not Applicable

Completed

Conditions: Epilepsy Intractable

Interventions: Drug: Ciprofloxacin Oral Product

First Posted Date: 2021-02-21

Last Posted Date: 2021-06-07

Lead Sponsor: Mazandaran University of Medical Sciences

Target Recruit Count: 23

Registration Number: NCT04763070

Locations: 🇮🇷
Bu Ali Sina hospital, Sari, Mazandaran, Iran, Islamic Republic of

Efficacy of Ticagrelor Plus Aspirin in Mild Non-cardioembolic Ischemic Stroke

Phase 3

Completed

Conditions: Ischemic Stroke
Transient Ischemic Attack

Interventions: Drug: Clopidogrel 75 mg
Drug: Ticagrelor 90mg

First Posted Date: 2021-02-04

Last Posted Date: 2023-10-19

Lead Sponsor: Mazandaran University of Medical Sciences

Target Recruit Count: 90

Registration Number: NCT04738097

Locations: 🇮🇷
Athena Sharifi Razavi, Sari, Mazandaran, Iran, Islamic Republic of
🇮🇷
Bou-Ali Sina hospital , Mazandarn University of Medical Science, Sari, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy